Search research articles
Contact Us
Filters
Showing results (301-310 of 466) with videos related to
Page
of 47
Sort By:
Blood
|
January 29, 2021
B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide
Moritz Fürstenau, Anna Maria Fink, Anke Schilhabel, et al.
Blood
|
June 30, 2023
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial
John F Seymour, John C Byrd, Paolo Ghia, et al.
American Journal of Hematology
|
May 17, 2024
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations
Petra Langerbeins, Adam Giza, Sandra Robrecht, et al.
Blood
|
July 17, 2009
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
Barbara F Eichhorst, Raymonde Busch, Stephan Stilgenbauer, et al.
Blood
|
April 27, 2019
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
Andrew W Roberts, Shuo Ma, Thomas J Kipps, et al.
European Journal of Immunology
|
March 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients
Igor Kos, Benedikt Balensiefer, Vadim Lesan, et al.
Blood
|
January 29, 2021
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
Lorenz Thurner, Natalie Fadle, Jörg Thomas Bittenbring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2011
Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group
Kirsten Fischer, Paula Cramer, Raymonde Busch, et al.
Hemasphere
|
March 14, 2022
Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
Nadine Kutsch, Christian Pallasch, Eugen Tausch, et al.
International Journal of Cancer
|
June 15, 2017
TP53 mutation and survival in aggressive B cell lymphoma
Thorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Page
of 47
Search research articles
Search
Showing results (301-310 of 466) with videos related to
Sort By:
Page
of 47
Blood
|
January 29, 2021
B-cell acute lymphoblastic leukemia in patients with chronic lymphocytic leukemia treated with lenalidomide
Moritz Fürstenau, Anna Maria Fink, Anke Schilhabel, et al.
Blood
|
June 30, 2023
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in the ELEVATE-RR trial
John F Seymour, John C Byrd, Paolo Ghia, et al.
American Journal of Hematology
|
May 17, 2024
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations
Petra Langerbeins, Adam Giza, Sandra Robrecht, et al.
Blood
|
July 17, 2009
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
Barbara F Eichhorst, Raymonde Busch, Stephan Stilgenbauer, et al.
Blood
|
April 27, 2019
Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables
Andrew W Roberts, Shuo Ma, Thomas J Kipps, et al.
European Journal of Immunology
|
March 31, 2021
Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients
Igor Kos, Benedikt Balensiefer, Vadim Lesan, et al.
Blood
|
January 29, 2021
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome
Lorenz Thurner, Natalie Fadle, Jörg Thomas Bittenbring, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 17, 2011
Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group
Kirsten Fischer, Paula Cramer, Raymonde Busch, et al.
Hemasphere
|
March 14, 2022
Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
Nadine Kutsch, Christian Pallasch, Eugen Tausch, et al.
International Journal of Cancer
|
June 15, 2017
TP53 mutation and survival in aggressive B cell lymphoma
Thorsten Zenz, Markus Kreuz, Maxi Fuge, et al.
Page
of 47